Literature DB >> 27987414

Targeting antigens to Dec-205 on dendritic cells induces a higher immune response in chickens: Hemagglutinin of avian influenza virus example.

David Jáuregui-Zúñiga1, Martha Pedraza-Escalona1, Gerardo Pavel Espino-Solís1, Verónica Quintero-Hernández1, Alejandro Olvera-Rodríguez1, Marco Aurelio Díaz-Salinas2, Susana López2, Lourival Domingos Possani3.   

Abstract

It is widely known that targeting a variety of antigens to the DEC-205 receptor on dendritic cells (DCs) significantly potentiate immunity. This communication reports the development of a new murine monoclonal antibody (mAb) against the chicken DEC-205, using as immunogen the carbohydrate recognition domain-2 (CRD-2) heterologously expressed. This mAb recognizes a protein band of 250kDa by immunoprecipitation analysis and shows strong cross-reactivity with human and pig DEC-205. Furthermore, the hemagglutinin (HA) of avian influenza H5N2 virus was cloned and expressed using insect cell-baculovirus expression system. We chemically conjugated the anti-chicken DEC-205 antibody with the highly purified HA to direct the antigen to the dendritic cells and evaluate the immune response elicited in vivo by this conjugate. A single dose of chemical conjugate was sufficient to elicit a strong immune response in chickens as early as fourteen days after priming. In addition, the conjugate induced an earlier and higher response compared to unconjugated HA. These results suggest that the strategy described here has potential to be used in the future design and development of successful vaccines against different chicken infectious diseases with direct impact in biotechnology and veterinary fields.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antigen targeting; Avian influenza; DEC-205; Hemagglutinin

Mesh:

Substances:

Year:  2016        PMID: 27987414     DOI: 10.1016/j.rvsc.2016.12.002

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


  7 in total

1.  Antigen Targeting of Porcine Skin DEC205+ Dendritic Cells.

Authors:  Edgar Alonso Melgoza-González; Mónica Reséndiz-Sandoval; Diana Hinojosa-Trujillo; Sofía Hernández-Valenzuela; Melissa García-Vega; Verónica Mata-Haro; Araceli Tepale-Segura; Laura C Bonifaz; Armando Perez-Torres; Jesús Hernández
Journal:  Vaccines (Basel)       Date:  2022-04-26

Review 2.  Enhancing Protective Efficacy of Poultry Vaccines through Targeted Delivery of Antigens to Antigen-Presenting Cells.

Authors:  Angita Shrestha; Jean-Remy Sadeyen; Munir Iqbal
Journal:  Vaccines (Basel)       Date:  2018-11-15

Review 3.  Immunomodulation of Avian Dendritic Cells under the Induction of Prebiotics.

Authors:  Vladimir Zmrhal; Petr Slama
Journal:  Animals (Basel)       Date:  2020-04-17       Impact factor: 2.752

4.  DEC-205 receptor-mediated long-circling nanoliposome as an antigen and Eucommia ulmoides polysaccharide delivery system enhances the immune response via facilitating dendritic cells maturation.

Authors:  Haibo Feng; Xiaonong Yang; Jing Fan; Linzi Zhang; Qianqian Liu; Dongkun Chai
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

5.  Haemagglutinin antigen selectively targeted to chicken CD83 overcomes interference from maternally derived antibodies in chickens.

Authors:  Angita Shrestha; Rick Meeuws; Jean-Remy Sadeyen; Pengxiang Chang; Marielle Van Hulten; Munir Iqbal
Journal:  NPJ Vaccines       Date:  2022-03-03       Impact factor: 9.399

6.  Selectively targeting haemagglutinin antigen to chicken CD83 receptor induces faster and stronger immunity against avian influenza.

Authors:  Angita Shrestha; Jean-Remy Sadeyen; Deimante Lukosaityte; Pengxiang Chang; Adrian Smith; Marielle Van Hulten; Munir Iqbal
Journal:  NPJ Vaccines       Date:  2021-07-15       Impact factor: 7.344

Review 7.  C-Type Lectins in Veterinary Species: Recent Advancements and Applications.

Authors:  Dimitri Leonid Lindenwald; Bernd Lepenies
Journal:  Int J Mol Sci       Date:  2020-07-20       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.